Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion.
about
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.Cardiorenal syndromes.Iron metabolism in hemodialyzed patients - a story half told?Iron, anaemia, and inflammatory bowel diseases.Iron therapy for renal anemia: how much needed, how much harmful?Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD.Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and AnemiaIron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel diseaseIntravenous iron therapy: well-tolerated, yet not harmless.Drug insight: Safety of intravenous iron supplementation with sodium ferric gluconate complex.Angina pectoris and intensive intravenous iron treatment in hemodialysis patients.Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis.Iron enhances endothelial cell activation in response to Cytomegalovirus or Chlamydia pneumoniae infection.Iron toxicity: relevance for dialysis patients.The Labile Side of Iron Supplementation in CKDDistinct immunologic effects of different intravenous iron preparations on monocytesFerric pyrophosphate citrate as an iron replacement agent for patients receiving hemodialysis.Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients.Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients.Effect of intravenous iron on haemodialysis catheter microbial colonization and blood-borne infection.Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis.
P2860
Q34333986-F8E5E3A4-2664-45AA-82AD-DE90BEB302C6Q34538721-1D54D87E-DA26-4DE1-B4D9-72D895FB234CQ34974326-AE423CFA-08C2-418D-A0E9-62CA829D6638Q35596692-A4D3D652-1107-423A-9FCA-D4E6973AF1C5Q35650627-0383A5EE-5E69-49AD-9059-4F845F8EFBC7Q35857178-E1A87711-AA93-4A49-BF69-1F1351E6112CQ35893998-DD3404E2-EB93-4F1F-9564-0C459600FF4FQ36043365-03C73C42-4D3D-4988-B6F8-F9F301CFD02BQ36310902-B7DD2971-02A4-4354-B378-139FCE8A554CQ36577123-D4A9F6C0-4D1E-4816-9DBF-A68709257D3AQ36765940-AE220B82-1E41-47FA-BCA7-A2F7FC761DFEQ36946004-8C9AEC4A-DB9A-4C02-9376-45A907DAB294Q37861473-B1027D20-3DF2-4BB2-95A4-65AE6FAA4CF9Q38156094-80B4A4A4-9D1E-4511-82A3-DD6110A8409BQ38496987-96A8E7B7-8E59-49D9-9A33-A749AFEDC0C0Q38541320-A79D08D3-E427-46CD-B8A0-F1ABB27B3C27Q39216391-1C0F7101-23EB-4A7F-80BE-59D868E62E83Q43910634-3B5BC19A-D19C-4911-BD9E-9D4F8DEF54F1Q44101580-8FE4C135-C012-4812-ADDE-915CFB7300D2Q46475705-2D784184-4E2D-4A20-BD69-3633F7AEE5C7Q46705821-ED9D53D4-5E0E-4486-AC64-7558A6E40993Q51753810-194B56B7-639A-415C-A5D1-1FB2AFAE5E0B
P2860
Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Nontransferrin-bound iron in t ...... nous iron saccharate infusion.
@en
Nontransferrin-bound iron in t ...... nous iron saccharate infusion.
@nl
type
label
Nontransferrin-bound iron in t ...... nous iron saccharate infusion.
@en
Nontransferrin-bound iron in t ...... nous iron saccharate infusion.
@nl
prefLabel
Nontransferrin-bound iron in t ...... nous iron saccharate infusion.
@en
Nontransferrin-bound iron in t ...... nous iron saccharate infusion.
@nl
P2093
P2860
P1476
Nontransferrin-bound iron in t ...... nous iron saccharate infusion.
@en
P2093
Gosriwatana I
Kersting S
Kooistra MP
Nijhoff-Schutte J
P2860
P356
10.1046/J.1365-2362.2002.0320S1036.X
P478
32 Suppl 1
P577
2002-03-01T00:00:00Z